Ibrutinib by Team Onco July 8, 2022 July 8, 2022 Ibrutinib is a targeted therapy drug used to treat mantle cell lymphoma, chronic lymphocytic leukemia, marginal zone lymphoma, waldenstrom’s macroglobulinemia, chronic graft vs host disease, and small lymphocytic lymphoma.
